Cefixime & Potassium Clavulanate Suspension – Zefral CV Suspension

Cefixime & Potassium Clavulanate Suspension – Enhanced β-Lactam Protection for Resistant Bacterial Infections.

Zefral CV Suspension – The Dual combination of Cefixime 50mg + Potassium Clavulanate Diluted 31.25mg. – Zefral CV Suspension is the power of a 3rd-generation cephalosporin with a β-lactamase inhibitor, where Cefixime disrupts bacterial cell wall synthesis, causing cell death, and Clavulanic Acid neutralizes β-lactamase enzymes that otherwise degrade Cefixime.

Recommended By Specialists:
Pediatricians: It is mainly used to prefer this combination to treat the disease associated with treating bacterial infections like Otitis media (ear infections), Urinary tract infections
General Physician: It is mainly used to treat mild to moderate community-acquired infections

Key Benefits of Cefixime & Potassium Clavulanate Suspension – Zefral CV Suspension
Potent β-Lactamase Inhibition – Clavulanic Acid extends Cefixime’s spectrum by inhibiting β-lactamase enzymes, making it highly effective against resistant strains.
Synergistic Broad-Spectrum Activity – Active against gram-positive, gram-negative, and β-lactamase-producing bacteria for robust infection control.
Improved Clinical Outcomes – Particularly beneficial in recurrent or chronic infections where resistance to standalone cephalosporins may occur

INDICATIONS:
Lower Respiratory Tract Infections
Recurrent Tonsillitis & Pharyngitis
Chronic or Recurrent UTIs
Otitis Media
Skin & Soft Tissue Infections
Resistant Typhoid & Paratyphoid Fever